Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity

Induction Effects of Ritonavir: Implications for Drug Interactions

(2008) Michelle M Foisy et al.   ANNALS OF PHARMACOTHERAPY

Rapid Clinical Induction of Hepatic Cytochrome P4502B6 Activity by Ritonavir

(2008) E. D. Kharasch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Simultaneous Population Pharmacokinetic Model for Lopinavir and Ritonavir in HIV-Infected Adults

(2008) José Moltó et al.   CLINICAL PHARMACOKINETICS

Effect of an Antiretroviral Regimen Containing Ritonavir Boosted Lopinavir on Intestinal and Hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected Patients

(2008) C Wyen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Dose–Response of Ritonavir on Hepatic CYP3A Activity and Elvitegravir Oral Exposure

(2008) AA Mathias et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Effect of Atazanavir and Atazanavir/Ritonavir on UDP-Glucuronosyltransferase Using Lamotrigine as a Phenotypic Probe

(2008) DM Burger et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals

(2008) L. Dickinson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line

(2008) Jason A. Zastre et al.   JOURNAL OF NEUROSCIENCE RESEARCH